Batimastat inhibitor of matrix metalloproteinase: A Phase III U.K. trial in 150 patients has been suspended after a majority of patients reported pain and disco

BBIOY has linked the reactions to specific changes in the final stage of manufacturing made during the course of scale-up of the manufacturing process, and will resort to the original process for making the drug.

The company is manufacturing new supplies of Batimastat and the program is expected to resume in June. The first trial in the resumed program will be a dose-escalation study. ...